GW Pharmaceuticals/Greenwich Biosciences
Epidiolex is a prescription cannabidiol that is used to treat seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients that are two years of age or older.
The prescription CBD significantly reduces seizures in patients who have previously failed on multiple seizure medications.
Common side effects associated with Epidiolex include sleepiness, decreased appetite, diarrhea, increased liver enzymes, feeling very tired and weak, rash, sleep problems and infections.
Filed Under: Drug Discovery, Drug Discovery and Development, Neurological Disease, Oncology, Orphan Drugs